MEPE
Basic information
Region (hg38): 4:87821398-87846814
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MEPE gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 34 | 10 | 50 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 12 | 11 |
Variants in MEPE
This is a list of pathogenic ClinVar variants found in the MEPE region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-87838656-A-C | not specified | Uncertain significance (Feb 07, 2023) | ||
4-87838679-G-T | not specified | Uncertain significance (Jul 16, 2024) | ||
4-87839749-C-G | MEPE-related disorder | Likely benign (Aug 27, 2024) | ||
4-87844990-A-T | MEPE-related disorder | Benign (Jan 07, 2020) | ||
4-87845004-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
4-87845004-G-T | not specified | Uncertain significance (Jul 12, 2022) | ||
4-87845045-A-G | MEPE-related disorder | Likely benign (Jan 07, 2020) | ||
4-87845066-GGAAA-G | MEPE-related disorder | Uncertain significance (Sep 27, 2024) | ||
4-87845082-T-C | MEPE-related disorder | Likely benign (Aug 22, 2024) | ||
4-87845084-G-C | MEPE-related disorder | Uncertain significance (Aug 08, 2024) | ||
4-87845116-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
4-87845133-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
4-87845164-A-T | not specified | Uncertain significance (Feb 10, 2022) | ||
4-87845172-A-G | not specified | Uncertain significance (Jul 27, 2024) | ||
4-87845221-C-T | MEPE-related disorder • not specified | Uncertain significance (Sep 27, 2021) | ||
4-87845232-G-T | not specified | Uncertain significance (Jul 14, 2024) | ||
4-87845233-G-A | MEPE-related disorder | Uncertain significance (Nov 01, 2022) | ||
4-87845252-T-C | MEPE-related disorder | Likely benign (Jan 07, 2020) | ||
4-87845298-G-A | MEPE-related disorder | Uncertain significance (Dec 06, 2023) | ||
4-87845347-C-T | not specified | Likely benign (Aug 02, 2021) | ||
4-87845358-C-G | not specified | Uncertain significance (May 22, 2023) | ||
4-87845436-C-T | not specified | Uncertain significance (May 23, 2023) | ||
4-87845448-A-G | not specified | Uncertain significance (Dec 06, 2021) | ||
4-87845466-G-C | not specified | Uncertain significance (Dec 10, 2024) | ||
4-87845484-A-G | MEPE-related disorder | Benign (May 23, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MEPE | protein_coding | protein_coding | ENST00000424957 | 3 | 25407 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00863 | 0.813 | 125635 | 0 | 77 | 125712 | 0.000306 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.188 | 268 | 277 | 0.968 | 0.0000132 | 3546 |
Missense in Polyphen | 50 | 55.167 | 0.90634 | 790 | ||
Synonymous | 0.827 | 87 | 97.4 | 0.893 | 0.00000488 | 935 |
Loss of Function | 1.06 | 4 | 7.03 | 0.569 | 3.82e-7 | 81 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000415 | 0.000413 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000550 | 0.000545 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000992 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes renal phosphate excretion and inhibits intestinal phosphate absorption (PubMed:14962809, PubMed:19005008). Promotes bone mineralization by osteoblasts and cartilage mineralization by chondrocytes (PubMed:18162525, PubMed:19998030, PubMed:22766095). Regulates the mineralization of the extracellular matrix of the craniofacial complex, such as teeth, bone and cartilage (By similarity). Promotes dental pulp stem cell proliferation and differentiation (PubMed:22341070). {ECO:0000250|UniProtKB:Q8K4L6, ECO:0000269|PubMed:14962809, ECO:0000269|PubMed:18162525, ECO:0000269|PubMed:19005008, ECO:0000269|PubMed:19998030, ECO:0000269|PubMed:22341070, ECO:0000269|PubMed:22766095}.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- loftool
- 0.975
- rvis_EVS
- 1.67
- rvis_percentile_EVS
- 96.29
Haploinsufficiency Scores
- pHI
- 0.237
- hipred
- N
- hipred_score
- 0.169
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00706
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mepe
- Phenotype
- hematopoietic system phenotype; skeleton phenotype; immune system phenotype;
Gene ontology
- Biological process
- skeletal system development;biomineral tissue development;post-translational protein modification;cellular protein metabolic process
- Cellular component
- endoplasmic reticulum lumen;extracellular matrix
- Molecular function
- extracellular matrix structural constituent;protein binding;extracellular matrix protein binding